Releases & Announcements

In the Spotlight

NCATS Director Christopher P. Austin, M.D.

Dr. Christopher P. Austin to Step Down as NCATS Director

NCATS ∙ 03/18/2021 ∙ Director's Statement

Christopher P. Austin, M.D., announced he will step down from his position as NCATS director on April 15, 2021. Deputy Director Joni L. Rutter, Ph.D., will serve as acting director while a national search is underway.

April 2021

Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms
NCATS ∙ 04/19/2021 ∙ CTSA Program
Drug Testing Approach Uncovers Effective Combination for Treating Small Cell Lung Cancer
NCATS ∙ 04/12/2021 ∙ Division of Preclinical Innovation
NIH-Funded Research Team Develops Language Test for People with Down Syndrome
NCATS, NICHD ∙ 04/08/2021 ∙ CTSA Program

March 2021

Dr. Christopher P. Austin to Step Down as NCATS Director
NCATS ∙ 03/18/2021 ∙ Director's Statement
NIH Statement on the Departure of Dr. Christopher Austin
The NIH Director ∙ 03/18/2021 ∙ NCATS, NIH
Assessing a Compound’s Activity, Not Just Its Structure, Could Deepen the Pool of Promising Drug Therapies
NCATS ∙ 03/03/2021 ∙ Division of Preclinical Innovation
NCATS Director Statement in Support of Ending Structural Racism and Health Disparities
NCATS ∙ 03/01/2021 ∙ Director's Statement

January 2021

DNA-Editing Method Shows Promise to Treat Mouse Model of Progeria
NCATS, NHGRI ∙ 01/06/2021 ∙ Somatic Cell Genome Editing

December 2020

Higher Red Cell Transfusion Threshold Offers No Advantage for Treating Preterm Infants
NCATS, NICHD, NHLBI ∙ 12/30/2020 ∙ NIH
NIH to Support Radical Approaches to Nationwide COVID-19 Testing and Surveillance
NCATS, NIH ∙ 12/21/2020 ∙ NCATS

November 2020

PaVe-GT: Collaborative NIH Effort Aimed at Creating a Gene Therapy Playbook, Making Rare Disease Treatments More Accessible
NCATS ∙ 11/30/2020 ∙ Rare Diseases
Commonly Used Antibiotic Shows Promise for Combating Zika Infections
NCATS, NINDS ∙ 11/24/2020 ∙ Division of Preclinical Innovation
Hydroxychloroquine Does Not Benefit Adults Hospitalized with COVID-19
NCATS, NHLBI ∙ 11/09/2020 ∙ CTSA Program

October 2020

NCATS Team’s Rapid Test Finds Promising Therapies for Myositis
NCATS ∙ 10/22/2020 ∙ Rare Diseases
NIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
NCATS, NIH ∙ 10/16/2020 ∙ CTSA Program
NCATS Translational Science Training Program Sets Young Scientists on Paths to Career Success
NCATS ∙ 10/13/2020 ∙ Division of Preclinical Innovation

September 2020

NIH Awards $35.5 Million to Use Tiny, Bioengineered Organ Models to Improve Clinical Trials’ Development and Design
NCATS ∙ 09/29/2020 ∙ Tissue Chip
NIH Expands Clinical Trials to Test Convalescent Plasma Against COVID-19
NCATS, NIH ∙ 09/22/2020 ∙ CTSA Program
NCATS, NRL Create Nanoparticle SARS-CoV-2 Model to Speed Drug Discovery for COVID-19
NCATS ∙ 09/18/2020 ∙ TRND
Announcement: Access to the COVID-19 Data Analytics Platform Now Open
NCATS ∙ 09/02/2020 ∙
Study Ties COVID-19-Related Syndrome in Kids to Altered Immune System
NIH ∙ 09/01/2020 ∙ GARD

August 2020

Rare Diseases Are Not Rare: Gallery of Creative Work Raises Awareness of Rare Diseases
NCATS, NIH ∙ 08/25/2020 ∙ Rare Diseases
NIH-Supported Scientists Demonstrate How Genetic Variations Cause Eczema
NCATS, NIAID ∙ 08/14/2020 ∙ CTSA Program

June 2020

NIH Launches Analytics Platform to Harness Nationwide COVID-19 Patient Data to Speed Treatments
NCATS, NIH ∙ 06/15/2020 ∙ CTSA Program, NCATS
New Imaging Method Tracks Brain’s Elusive Networks
NCATS, NIBIB ∙ 06/10/2020 ∙ NIH

May 2020

NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community
NCATS, NIH ∙ 05/07/2020 ∙ RDCRN

April 2020

NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection
NCATS, NIAID ∙ 04/10/2020 ∙ NCATS